Zevra Therapeutics, Inc. (ZVRA) Shareholders’ equity 2018–2025
Zevra Therapeutics, Inc. (ZVRA) shareholders’ equity at each fiscal year-end, per SEC filings.
$154.7MFY2025 · since FY2018: -$66.6M → $154.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $154.7M | +289.9% |
| FY2024 | $39.7M | -35.9% |
| FY2023 | $61.9M | -17.6% |
| FY2022 | $75.1M | -26.1% |
| FY2021 | $101.7M | +253.1% |
| FY2020 | -$66.4M | +10.8% |
| FY2019 | -$74.5M | -11.9% |
| FY2018 | -$66.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice